GILD Competitors & Alternatives
Compare Gilead Sciences Inc with similar stocks in the same industry
Drug Manufacturers - General
GILD
Main Stock$156.30
Tradestie Score
50
Market Cap
$137.92B
Revenue Growth
0.1%
Analyst Upside
+2.3%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVO
Novo-Nordisk A/S
|
$38.62
|
$262.92B | 9.6 | 61 | Compare |
|
AZN
AstraZeneca PLC
|
$165.54
|
$261.56B | 23.9 | 59 | Compare |
|
NVS
Novartis AG
|
$150.36
|
$254.99B | 22.7 | 39 | Compare |
|
MRK
Merck & Co., Inc.
|
$146.27
|
$225.13B | 115.2 | 67 | Compare |
|
AMGN
Amgen Inc
|
$432.47
|
$160.70B | 27.0 | 39 | Compare |
|
PFE
Pfizer Inc.
|
$29.48
|
$154.70B | 38.7 | 39 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$40.01
|
$121.27B | 21.2 | 69 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$59.24
|
$96.54B | 12.5 | 58 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$49.63
|
$91.59B | 15.5 | 42 | Compare |
|
REGN
Regeneron Pharmaceuticals Inc
|
$790.82
|
$63.59B | 19.7 | 55 | Compare |
More GILD Analysis
Data updated: Oct 19, 2026 | Industry: Drug Manufacturers - General (SIC 2836)
17 stocks in this industry